- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00751686
Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece
February 14, 2013 updated by: GlaxoSmithKline
To Estimate the Burden of Rotavirus Gastroenteritis (RV GE) in Children < 5 Years of Age in Greece
The purpose of this study is to measure the disease burden from RV GE among children less than 5 years of age using hospital surveillance data.
In addition, data collected will determine the seasonal distribution, disease severity, age distribution of RV GE.
From an economic standpoint, the cost and impact of RV will also be assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
128
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Athens, Greece, 11527
- GSK Investigational Site
-
Athens, Greece, 104 46
- GSK Investigational Site
-
Heraklion, Crete, Greece, 71409
- GSK Investigational Site
-
Rio/Patras, Greece, 26500
- GSK Investigational Site
-
Thessaloniki, Greece, 54636
- GSK Investigational Site
-
Thessaloniki, Greece, 546 38
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children < 5 years of age seen at the selected hospital sites for acute GE (e.g.
subjects treated at the hospital or visiting the emergency room for an acute GE episode or developed acute GE at least 48 hours after hospitalisation) with a rapid screen positive test result to RV.
Description
Inclusion Criteria:
- A male or female child < 5 years of age at the time of the visit (a child becomes ineligible on the day of her/his 5th birthday).
- Child is brought to the emergency room for acute GE during the study period or develop acute GE at least 48 hours after hospitalisation.
- Written informed consent obtained from the parent/guardian of the subject.
- Children with RV positive stool sample will be enrolled in the study.
Exclusion Criteria:
• Not applicable.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
RV GE Group
|
Collection of the stool at least 48 hours after hospitalisation.
Stool samples should be obtained preferably within 4 and no later than 10 days after the onset of the GE symptoms.
Logbook, Health Economic Questionnaire, Telephone call.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Estimation of the proportion of RV GE among all acute GE emergency room visits among children <5 years of age.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Estimation of the proportion of RV GE among all acute GE hospitalisations among children <5 years of age.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Estimation of the incidence of nosocomial RV GE among all hospitalised children <5 years of age.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determination of the age of the children, disease severity, and the seasonal distribution of RV GE among children <5 years of age.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Assessing the costs related to the episodes of RV GE, by the completion of the Health Economic Questionnaire (interview with the parent for a subset of subjects) and the cost checklist provided by the hospital's site staff.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Identification of prevalent genotypes of RV among children <5 years of age.
Time Frame: Approximately 12 months
|
Approximately 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
September 11, 2008
First Submitted That Met QC Criteria
September 11, 2008
First Posted (Estimate)
September 12, 2008
Study Record Updates
Last Update Posted (Estimate)
February 18, 2013
Last Update Submitted That Met QC Criteria
February 14, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 109355
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotavirus Gastroenteritis
-
GlaxoSmithKlineCompletedRotavirus Gastroenteritis | Nosocomial Rotavirus Gastroenteritis
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus Gastroenteritis
-
Romark Laboratories L.C.CompletedRotavirus Infection | Viral Gastroenteritis Due to RotavirusEgypt
-
Merck Sharp & Dohme LLCCompletedRotavirus Gastroenteritis
-
Merck Sharp & Dohme LLCCompletedRotavirus Gastroenteritis
-
Christian Medical College, Vellore, IndiaKarolinska InstitutetCompletedRotavirus GastroenteritisIndia
-
GlaxoSmithKlineCompletedRotavirus GastroenteritisBrazil
-
University of ChileBharat Biotech International LimitedRecruitingRotavirus GastroenteritisChile
-
PT Bio FarmaCompletedRotavirus GastroenteritisIndonesia
Clinical Trials on Stool sample
-
Duke UniversityUniversity of South Florida; Children's Hospital Los AngelesCompletedInfant Immunity Response and Immunoglobulin DiversityUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingComplication | Hematologic Malignancy | Hematopoietic Stem Cell Transplantation | Chronic Graft-versus-host-diseaseChina
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHeart FailureUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingVascular Diseases | Common Variable ImmunodeficiencyFrance
-
University Hospital, Clermont-FerrandInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementRecruitingInflammatory Bowel Diseases | Diabetes type1 | Juvenile Idiopathic ArthritisFrance
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingNarcolepsy Type 1 | Bacterial TranslocationFrance
-
The First Affiliated Hospital of Soochow UniversityRecruitingGraft Vs Host DiseaseChina
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid LeukemiaUnited States